Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03697070 · ClinicalTrials.gov registry record · NA
The INSPIRE-ASP PNA Trial
A NA study of Pneumonia, sponsored by Harvard Pilgrim Health Care.
- Completed
- Registry status
- NA
- Development phase
- 44,780
- Enrollment target
- 20
- Study locations
NCT03697070: Completed NA study of Pneumonia, sponsored by Harvard Pilgrim Health Care.
NCT03697070 is a NA study of Pneumonia that has completed, run by Harvard Pilgrim Health Care. The registered enrollment target is 44,780 participants, above the 3,567-participant average among 47 other Pneumonia trials with a reported enrollment target (1155% higher). The trial reports 20 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03697070, a NA study of Pneumonia, has completed, sponsored by Harvard Pilgrim Health Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 44,780 participants
- Enrollment target
- 20
- Study locations
Study Summary
The INSPIRE-ASP PNA trial is a cluster-randomized controlled trial of HCA hospitals comparing routine empiric antibiotic stewardship practices with real-time precision medicine computerized physician order entry smart prompts providing the probability that a non-critically ill adult admitted with PNA is infected with a resistant pathogen. Note: that enrolled "subjects" represents 59 individual HCA hospitals that have been randomized.
Primary Outcome
The number of different extended-spectrum antibacterials received by the patient each empiric day-of-therapy (outcome measure unit), averaged over the empiric days (the first 3 days of hospitalization), summed across all participants. Note that Days-of-Therapy unit is a standardized national measure for antibacterial use in hospitals. For clarity the calculation is as follows: we define a DOT for a particular ES antibiotic as a day in which any number of doses of that antibiotic is given. Differ
Conditions Studied
Interventions
- OTHER Routine Care
- OTHER INSPIRE CPOE Smart Prompt
Study Locations (20)
Florida
- Brandon Regional - Brandon
- Fort Walton Medical Center - Fort Walton Beach
- North Florida Regional Medical Center - Gainesville
- Osceola Regional Medical Center - Kissimmee
- Poinciana Medical Center - Kissimmee
- Lake City Medical Center - Lake City
- Largo Medical Center - Largo
- Northwest Medical Center - Margate
- Kendall Regional Medical Center - Miami
- Twin Cities Hospital - Niceville
- Putnam Community Medical Center - Palatka
- Gulf Coast Medical Center - Panama City
- Westside Regional Medical Center - Plantation
Colorado
- The Medical Center of Aurora - Aurora
- Swedish Medical Center - Denver
- Sky Ridge Medical Center - Denver
- Rose Medical Center - Denver
California
- Riverside Community Hospital - Riverside
- Regional Medical Center of San Jose - San Jose
- Los Robles Regional Medical Center - Thousand Oaks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44,780 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2024-05-16 |
| Phase | NA |
What the finished NCT03697070 record still lists
NCT03697070 is an interventional study that assigns participants to a tested intervention. Its 44,780 participants enrollment target places it among the larger protocols in the corpus, above the 3,567-participant average among 47 other Pneumonia trials with a reported enrollment target (1155% higher).
The record links to 1 condition, with Pneumonia appearing as the primary indexed condition, and to 2 interventions - of which Routine Care is the first listed.
NCT03697070 names 20 study sites across 3 states, led by Florida, Colorado, California.
Frequently Asked Questions
What is clinical trial NCT03697070 about?
NCT03697070 is a clinical study titled "The INSPIRE-ASP PNA Trial". The INSPIRE-ASP PNA trial is a cluster-randomized controlled trial of HCA hospitals comparing routine empiric antibiotic stewardship practices with real-time precision medicine computerized physician order entry smart prompts providing the probability that a non-critically ill adult admitted with PN...
What is the current status of trial NCT03697070?
This trial is currently completed. It is a NA study. The enrollment target is 44,780 participants. The study started on 2018-10-01. Estimated completion is 2024-05-16.
What conditions does trial NCT03697070 study?
This clinical trial studies the following conditions: Pneumonia.
What interventions are being tested in trial NCT03697070?
The interventions under investigation include: Routine Care (OTHER), INSPIRE CPOE Smart Prompt (OTHER).
Who is sponsoring clinical trial NCT03697070?
This trial is sponsored by Harvard Pilgrim Health Care, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03697070 being conducted?
This trial has 20 study locations across California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03697070's enrollment target sits among peer trials
44,780 2nd of 47 the highest of 47 other Pneumonia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pneumonia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
RECRUITING · NA
-
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05607732 · 45,257 participants · NA
Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
- NCT06824350 · 45,450 participants · NA
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
- NCT06597968 · 45,991 participants
Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
- NCT03977402 · 47,500 participants
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI